HEATHER COOK: Open Payments
NPI 1972227890 · HAMPTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 17 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $115 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $96 |
| Sumitomo Pharma America, Inc. | 3 | $84 |
| Janssen Biotech, Inc. | 4 | $61 |
| Procept Biorobotics Corporation | 1 | $27 |
| Ardelyx, Inc. | 1 | $18 |
| Celltrion USA Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
Products named: ENTYVIO, GEMTESA, TREMFYA, AQUABEAM ROBOTIC SYSTEM, IBSRELA, VEGZELMA, OMVOH, VOQUEZNA.
Industry payments across VA — which companies pay providers there.
